Nasacort AQ (triamcinolone acetonide) Nasal Spray

Company: Phone-Poulenc Rorer
Approval Status: Approved October 1997
Treatment for: allergic rhinitis
Areas: Pediatrics; Respiratory
Possible similar drugs: Nasacort AQ

| General Information |

General Information

Nasacort (R) AQ (triamcinolone acetonide) has been approved by the U.S. Food and Drug Administration (FDA) for use the treatment of nasal symptoms of seasonal and perennial allergic rhinitis in children aged 6-11. Nasacort in currently available in the U.S. for adults and children aged 12 years and older.

< back to top

Nasacort AQ Drug Information

The Nasacort Aq drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.